Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.59 |
| ▸ | FAAH | O00519 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | LHCGR | P22888 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4748350 | 0.83 | FAAH (0.64) | RAB9AALDH1A1EPHX1FAAH | |
| SCHEMBL8074322 | 0.83 | ALDH1A1 (0.76) | RAB9AALDH1A1EPHX1FAAHLHCGR | |
| SCHEMBL1690730 | 0.80 | RAB9A (0.71) | RAB9AALDH1A1NPC1EPHX1FAAH | |
| SCHEMBL482831 | 0.80 | ALDH1A1 (0.71) | RAB9AALDH1A1EPHX1FAAHLHCGR | |
| SCHEMBL1532563 | 0.80 | ALDH1A1 (1.00) | RAB9AALDH1A1EPHX1FAAHLHCGR | |
| SCHEMBL21618461 | 0.80 | ALDH1A1 (1.00) | RAB9AALDH1A1EPHX1FAAHLHCGR | |
| SCHEMBL8393776 | 0.80 | ALDH1A1 (1.00) | RAB9AALDH1A1EPHX1FAAHLHCGR | |
| SCHEMBL4190588 | 0.79 | ALDH1A1 (0.74) | RAB9AALDH1A1EPHX1FAAHLHCGR | |
| Bicarbonate SCHEMBL15226094 | 0.78 | ALDH1A1 (0.97) | RAB9AALDH1A1EPHX1FAAHLHCGR | |
| SCHEMBL5115600 | 0.78 | ALDH1A1 (0.97) | RAB9AALDH1A1EPHX1FAAHLHCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008129129-A1 | HETEROCYCLIC PHENYL CARBAMATES AS NOVEL FAAH-INHIBITORS | KUOPION YLIOPISTO (FI) | 2008-10-30 | — | — | WO | disclosed |